Cosmos Health (COSM) Gains from Sales and Divestitures (2018)

Cosmos Health (COSM) recorded quarterly Gains from Sales and Divestitures of $18750.0 in Q3 2018, up 50.0% on a QoQ basis from $12500.0 in Q2 2018.

Cosmos Health (COSM) Gains from Sales and Divestitures (2018) Analysis & Trends

Cosmos Health has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $18750.0 for Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Akso Health	2,315,158.81 Bn	2,315,158.63 Bn	-
2	Mckesson	92.76 Bn	89.18 Bn	4.04 Bn
3	Cencora	52.82 Bn	50.83 Bn	3.59 Bn
4	Cardinal Health	52.17 Bn	48.39 Bn	2.50 Bn
5	Henry Schein	9.19 Bn	9.71 Bn	1.07 Bn
6	Accendra Health	246.88 Mn	-90.00 Mn	312.39 Mn
7	Edap Tms	161.92 Mn	146.92 Mn	8.15 Mn
8	111	107.47 Mn	25.61 Mn	23.58 Mn
9	Cosmos Health	9.42 Mn	7.26 Mn	1.38 Mn
10	Cellyan Biotechnology	5.69	-2.48 Mn	-

Download Data